Effects of Associated Impairments on Activity and Participation in Children With Cerebral Palsy
Launched by HACETTEPE UNIVERSITY · Apr 17, 2025
Trial Information
Current as of May 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how additional health challenges, known as associated impairments, affect the activity levels and social participation of school-aged children with Cerebral Palsy. The study focuses on children aged 6 to 12 and aims to understand how these challenges impact their families' quality of life and the burden of caregiving.
To participate, children must have a diagnosis of Cerebral Palsy and be between the ages of 6 and 12, with family permission to join. Families should also be willing to take part in the study. However, children younger than 6 or older than 12, and those who do not speak Turkish or cannot read and write, will not be eligible. Participants can expect to share their experiences, and their insights will help improve understanding and support for children with Cerebral Palsy and their families.
Gender
ALL
Eligibility criteria
- For children:
- • Inclusion criteria
- • Having a diagnosis of cerebral palsy
- • Being between the ages of 6-12
- • Having family approval for the study Exclusion criteria
- • Being under the age of 6 and over the age of 12
- • Parents and children who do not volunteer to participate in the study
- • Not knowing Turkish
- For families:
- • Inclusion criteria
- • Having a child between the ages of 6-12 diagnosed with cerebral palsy
- • Being willing to participate in the study Exclusion criteria
- • Not being willing to participate in the study
- • Not knowing Turkish
- • Not being able to read and write
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Mintaze Kerem-Gunel, Professor
Study Director
Hacettepe University, Faculty of Physical Therapy and Rehabilitation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported